These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 17983826

  • 1. Australian Crohn's antibiotic study opens new horizons.
    Gitlin L, Biesecker J.
    Gastroenterology; 2007 Nov; 133(5):1743-4; author reply 1745-6. PubMed ID: 17983826
    [No Abstract] [Full Text] [Related]

  • 2. Importance of the Australian Crohn's disease antibiotic study.
    Chamberlin W.
    Gastroenterology; 2007 Nov; 133(5):1744-5; author reply 1745-6. PubMed ID: 17983827
    [No Abstract] [Full Text] [Related]

  • 3. The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study.
    Kuenstner JT.
    Gastroenterology; 2007 Nov; 133(5):1742-3; author reply 1745-6. PubMed ID: 17983824
    [No Abstract] [Full Text] [Related]

  • 4. Flawed Australian CD study does not end MAP controversy.
    Lipton JE, Barash DP.
    Gastroenterology; 2007 Nov; 133(5):1742; author reply 1745-6. PubMed ID: 17983825
    [No Abstract] [Full Text] [Related]

  • 5. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W, Pavli P, Crotty B, Florin T, Radford-Smith G, Gibson P, Mitchell B, Connell W, Read R, Merrett M, Ee H, Hetzel D, Antibiotics in Crohn's Disease Study Group.
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
    Shafran I, Kugler L, El-Zaatari FA, Naser SA, Sandoval J.
    Dig Liver Dis; 2002 Jan; 34(1):22-8. PubMed ID: 11930899
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis.
    Chamberlin W, Ghobrial G, Chehtane M, Naser SA.
    Am J Gastroenterol; 2007 Mar; 102(3):689-91. PubMed ID: 17335456
    [No Abstract] [Full Text] [Related]

  • 9. [Role of Mycobacterium avium paratuberculosis in the etiopathogenesis of Crohn's disease].
    Ormaechea JI, Gisbert JP, Marín-Jiménez I.
    Gastroenterol Hepatol; 2009 May; 32(5):353-63. PubMed ID: 19457586
    [No Abstract] [Full Text] [Related]

  • 10. Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: more evidence for a neglected public health tragedy.
    Hermon-Taylor J.
    Dig Liver Dis; 2002 Jan; 34(1):9-12. PubMed ID: 11926580
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
    Meier J, Sturm A.
    Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease.
    Hermon-Taylor J.
    Gut; 2001 Dec; 49(6):755-6. PubMed ID: 11709506
    [No Abstract] [Full Text] [Related]

  • 17. The causation of Crohn's disease and treatment with antimicrobial drugs.
    Hermon-Taylor J.
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):607-10. PubMed ID: 10076782
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
    Borody TJ, Leis S, Warren EF, Surace R.
    Dig Liver Dis; 2002 Jan; 34(1):29-38. PubMed ID: 11926571
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.